498O INDIGO: A Randomized, Double-Blinded, Phase III Study of Vorasidenib Versus Placebo in IDH1 or IDH2 Low-Grade GliomaD. Blumenthal,I. K. Mellinghoff,M. J. van den Bent,M. Touat, K. Peters,J. Clarke,J. Mendez,L. Welsh,W. Mason,A. F. Hottinger,J. M. Sepulveda Sanchez,W. Wick,R. Soffietti, A. Tron, D. Zhao, S. Pandya,L. Steelman, I. Hassan,P. Wen,T. CloughesyANNALS OF ONCOLOGY（2023）引用 0|浏览40关键词IDH MutationAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
